NEW YORK, May 07, 2018 -- Safirstein Metcalf LLP and HGT Law remind investors that a shareholder “opt-out” lawsuit (“Lawsuit”) has been filed on behalf of a group of retail investors (“Investors”) against Valeant Pharmaceuticals International, Inc. (“Valeant”) and its senior officers for violations of federal securities laws and invite investors to contact the firms.
Previously, on June 24, 2016, a class action complaint was filed in the U.S. District Court for the District of New Jersey, on behalf of a class consisting of all purchasers of the common stock of Valeant (“Class Action”). More than twenty lawsuits have been filed on behalf of institutional investors who have decided to opt out of the Class Action to directly pursue their own claims. To date, the Lawsuit commenced by Safirstein Metcalf LLP and HGT Law is the only opt-out lawsuit that has been filed on behalf of retail investors.
A copy of the complaint filed by Safirstein Metcalf LLP and HGT Law on behalf of the Investors can be found here. For more information on opt-out lawsuits, see our publication here.
If you purchased Valeant common stock during the period from January 4, 2013 through March 15, 2016 and suffered losses of more than $200,000, then you may wish to consider opting out of the existing class action and joining the Lawsuit. A number of large institutional investors such as T. Rowe Price, Blackrock and Prudential Insurance Company have already opted out of the class action. If you would like to learn about the options available to you, please call 1-800-221-0015, email [email protected] or visit www.valeantshareholderlitigation.com
Company: Valeant Pharmaceuticals International, Inc.
Exchange: NYSE
Ticker: VRX
Class Period: 01/04/2013 – 03/15/2016
About Safirstein Metcalf LLP and HGT Law
Safirstein Metcalf LLP focuses its practice on shareholder rights. The law firm also practices in the areas of antitrust and consumer protection. All of the Firm’s legal endeavors are rooted in its core mission: provide investor and consumer protection.
HGT Law is a boutique commercial litigation firm based in New York. The firm focuses on representing investors in securities litigation and corporate governance/derivative litigation.
Attorney advertising. Prior results do not guarantee a similar outcome.
Safirstein Metcalf LLP
Peter Safirstein, Esq.
Safirstein Metcalf LLP
The Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118


Samsung Appoints New TV Business Head Amid Rising Competition from Chinese Rivals
Ford Q1 Earnings Beat Expectations, Stock Surges on Strong Guidance
Starbucks Raises 2026 Outlook as Turnaround Strategy Boosts Sales and Earnings
GameStop Proposes $56 Billion eBay Acquisition in Bold Strategic Move
Why Paycom Was Named a 2026 Platinum Employer on the Where You Work Matters List
United Airlines Flight Hits Light Pole During Newark Landing, FAA Investigates
Qualcomm Stock Surges Despite Weak Guidance After Q2 2026 Earnings Beat
Microsoft Azure Growth Forecast Beats Expectations Amid Rising AI Competition
Berkshire Hathaway Meeting Sees Shift as Greg Abel Steps Into Leadership Spotlight
GameStop Eyes eBay Acquisition as Stock Prices Surge After Hours
Amazon Stock Dips Despite Record Earnings as AI Infrastructure Spending Surges
TSMC Exits Arm Holdings with $231 Million Share Sale Amid Strategic Portfolio Shift
NAB First-Half Earnings Miss Forecasts Amid Rising Global Risks
Meta Raises 2026 Capex Outlook Amid AI Spending Surge, Shares Drop After Earnings
Apple Q2 2026 Earnings Surge as iPhone 17 Sales Drive Record Revenue
U.S. Cybersecurity Pushes Faster Patch Deadlines Amid Rising AI-Driven Threats 



